Certara VP and Lead Scientist Evaluates Pivotal Study at Cardiac Safety Research Consortium Meeting
Study results support replacing the expensive and time-consuming TQT study with QT assessment in early clinical development PRINCETON, NJ – Dec. 23, 2014 – Certara®, the leading global technology-enabled drug development and drug safety consultancy, today announced that its Vice President and Lead Scientist Christine Garnett, PharmD, was session chair at the Dec.12 Cardiac Safety … Continued